Foreign
THE Russian State Research Center of Virology and Biotechnology Vector has started developing a new Coronavirus (COVID-19) vaccine in the form of nasal drops, an official said.
Vector General Director Rinat Maksyutov said in an interview with Sputnik that the vaccine would help provide immunity right at the “entrance gate” of the infection,
“Yes, we have started developing a vaccine in the form of drops, an intranasal vaccine.
“The composition of the main active component of the vaccine will remain unchanged (same as that of the EpiVacCorona vaccine),” Maksyutov said.
Tags: biotech research centre developing intranasal COVID-19 vaccine Russia’s virologyThe vaccine will help develop immunity in the nasal mucous membranes, which can be described as the “entrance gate” of the infection, Maksyutov specified. (Sputnik/NAN)
– Apr. 08, 2021 @ 10:59 GMT
Related Posts
Most Read
BusinessAfreximbank participates in Bank of Industry Nigeria’s syndicated facility of up to EUR 2-billionBy editor1 MIN READ
AfricaEnergy Industry Congratulates John Mahama on Re-election, Commends Progress in Oil and Gas SectorBy editor1 MIN READ
